Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -598.56% is 99% above its 5-year average of -85075.01%, near the high end of its 5-year range (-734471.43%–-161.80%).
14.98% below its 12-month average of -520.57%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -449.61%.
NET PROFIT MARGIN
-598.56%
NET PROFIT MARGIN AVG TTM
-520.57%
NET PROFIT MARGIN AVG 3Y
-27536.26%
NET PROFIT MARGIN AVG 5Y
-85075.01%
NET PROFIT MARGIN AVG 10Y
-129954.90%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-14.98%
CURRENT VS 3Y AVG
+97.83%
CURRENT VS 5Y AVG
+99.30%
CURRENT VS 10Y AVG
+99.54%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-230115.38%
vs the sector median at left
ImmunityBio, Inc.
Market Cap
$10.15B
Net Profit Margin
-598.56%
TTM Avg
-520.57%
3Y Avg
-27536.26%
5Y Avg
-85075.01%
Market Cap
$10.13B
Net Profit Margin
9.99%
TTM Avg
10.36%
3Y Avg
10.48%
5Y Avg
22.21%
Market Cap
$10.19B
Net Profit Margin
-0.02%
TTM Avg
1.97%
3Y Avg
2.41%
5Y Avg
2.58%
Market Cap
$10.24B
Net Profit Margin
-12.18%
TTM Avg
-18.34%
3Y Avg
-27.51%
5Y Avg
-50.59%
Market Cap
$10.03B
Net Profit Margin
6.90%
TTM Avg
6.89%
3Y Avg
6.71%
5Y Avg
6.89%
Market Cap
$10.31B
Net Profit Margin
17.03%
TTM Avg
11.20%
3Y Avg
12.20%
5Y Avg
12.89%
Market Cap
$9.93B
Net Profit Margin
8.59%
TTM Avg
-21.22%
3Y Avg
-48.94%
5Y Avg
16.61%
Market Cap
$10.40B
Net Profit Margin
-31.66%
TTM Avg
-43.66%
3Y Avg
-69.45%
5Y Avg
-91.35%
Market Cap
$9.87B
Net Profit Margin
5.29%
TTM Avg
1.30%
3Y Avg
7.86%
5Y Avg
11.15%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | $10.15B | -598.56% | -520.57% | -27536.26% | -85075.01% |
| Align Technology, Inc. (ALGN)vs › | $10.13B | 9.99% | 10.36% | 10.48% | 22.21% |
| Molina Healthcare, Inc. (MOH)vs › | $10.19B | -0.02% | 1.97% | 2.41% | 2.58% |
| 10x Genomics, Inc. (TXG)vs › | $10.24B | -12.18% | -18.34% | -27.51% | -50.59% |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 6.90% | 6.89% | 6.71% | 6.89% |
| Globus Medical, Inc. (GMED)vs › | $10.31B | 17.03% | 11.20% | 12.20% | 12.89% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 8.59% | -21.22% | -48.94% | 16.61% |
| Twist Bioscience Corporation (TWST)vs › | $10.40B | -31.66% | -43.66% | -69.45% | -91.35% |
| Repligen Corporation (RGEN)vs › | $9.87B | 5.29% | 1.30% | 7.86% | 11.15% |
| Henry Schein, Inc. (HSIC)vs › | $9.66B | 2.96% | 3.05% | 3.43% | 3.79% |
Operating Margin
-226.0%
Net Profit Margin
-598.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -449.61% |
| 2026-03-31 | -1431.44% |
| 2025-12-31 | -161.80% |
| 2025-09-30 | -209.77% |
| 2025-06-30 | -350.26% |
| 2025-03-31 | -784.92% |
| 2024-12-31 | -783.40% |
| 2024-09-30 | -1404.01% |
| 2024-06-30 | -12852.34% |
| 2024-03-31 | -335272.50% |
| 2023-12-31 | -167907.91% |
| 2023-09-30 | -116563.41% |
| 2023-06-30 | -336290.24% |
| 2023-03-31 | -32317.50% |
| 2022-12-31 | -148239.73% |
| 2022-09-30 | -94015.25% |
| 2022-06-30 | -270251.43% |
| 2022-03-31 | -734471.43% |
| 2021-12-31 | -23399.74% |
| 2021-09-30 | -132771.21% |
| 2021-06-30 | -26043.66% |
| 2021-03-31 | -57276.26% |
| 2020-12-31 | -153009.52% |
| 2020-09-30 | -43445.70% |
| 2020-06-30 | -11797.94% |
| 2020-03-31 | -22447.27% |
| 2019-12-31 | -2421.30% |
| 2019-09-30 | -129883.33% |
| 2019-06-30 | -98129.41% |
| 2019-03-31 | -357700.00% |
| 2018-12-31 | -247714.29% |
| 2018-09-30 | -76241.94% |
| 2018-06-30 | -693300.00% |
| 2018-03-31 | -550380.00% |
| 2017-12-31 | -204058.33% |
| 2017-09-30 | -299612.50% |
| 2017-06-30 | -167514.29% |
| 2017-03-31 | -222863.64% |
| 2016-12-31 | -173128.57% |
| 2016-09-30 | -265808.33% |
| 2016-06-30 | -283308.33% |
| 2016-03-31 | -510833.33% |
| 2015-12-31 | -548721.43% |
| 2015-09-30 | -426490.00% |
| 2015-06-30 | -92946.15% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
